Transgenic Group (TSE:2342) Short-Term Debt: 円1,136 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2342 Transgenic Group Inc TSE:2342
62 GF Score
Price 円258.00
GF Value 円255.94
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Transgenic Group Short-Term Debt?

Transgenic Group TSE:2342 +4.45% 62 Short-Term Debt is 円1,136 Mil as of Mar. 2026. GuruFocus rates TSE:2342 with a GF Score™ of 62/100 and a GF Value™ of 円255.94 (Fairly Valued). The stock has 4 warning signs investors should review.

Transgenic Group's Short-Term Debt for the quarter that ended in Mar. 2026 was 円1,136 Mil.

Transgenic Group's quarterly Short-Term Debt increased from Sep. 2025 (円1,705 Mil) to Dec. 2025 (円1,845 Mil) but then declined from Dec. 2025 (円1,845 Mil) to Mar. 2026 (円1,136 Mil).

Transgenic Group's annual Short-Term Debt increased from Mar. 2024 (円915 Mil) to Mar. 2025 (円1,219 Mil) but then declined from Mar. 2025 (円1,219 Mil) to Mar. 2026 (円1,136 Mil).

Transgenic Group Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Transgenic Group Short-Term Debt Related Terms

Transgenic Group Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Transgenic Group's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Transgenic Group Short-Term Debt Chart

Transgenic Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 727.94 662.03 914.73 1,218.66 1,136.36

Transgenic Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,604.59 1,705.28 1,844.70 1,136.36 1,764.81
TSE:2342
62GF Score
Transgenic Group Inc TSE:2342
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of 円1,136 Mil mean?
Transgenic Group (TSE:2342) has a Short-Term Debt of 円1,136 Mil as of Mar. 2026.
Is Transgenic Group's Short-Term Debt too high?
Transgenic Group's current Short-Term Debt is 円1,136 Mil. Overall, Transgenic Group has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Transgenic Group's Short-Term Debt compare to VRTX and REGN?
Transgenic Group's Short-Term Debt of 円1,136 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Biotechnology company?
A good Short-Term Debt depends on the Biotechnology industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Transgenic Group's current Short-Term Debt is 円1,136 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transgenic Group stock overvalued right now?
Based on GuruFocus' analysis, Transgenic Group (TSE:2342) is currently considered Fairly Valued. The stock's GF Value™ is 円255.94, compared to a current price of 円258.00 — trading 0.8% above its estimated fair value. The current Short-Term Debt is 円1,136 Mil. Transgenic Group's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Transgenic Group (TSE:2342), the current Short-Term Debt is 円1,136 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Transgenic Group (TSE:2342) Overvalued in 2026?

Based on GuruFocus' analysis, Transgenic Group stock appears to be overvalued. The current stock price of 円258.00 is trading 0.8% above its estimated GF Value™ of 円255.94. GuruFocus considers Transgenic Group to be Fairly Valued.

Key valuation signals for TSE:2342:

  • Short-Term Debt: 円1,136 Mil
  • GF Value™: 円255.94 vs. price of 円258.00 (0.8% above fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the TSE:2342 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Transgenic Group Business Description

Address 2-3-36 Tenjin, Chuo-ku, Fukuoka Prefecture, Fukuoka, JPN
Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals. The company has two segments: Drug discovery support business, and Investment and consulting business.
62GF Score

Get the complete analysis for TSE:2342

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円258.00
Price
円255.94
GF Value